Aug 4, 2026 08:00AM
Aug 3, 2026 08:00AM
Aug 3, 2026 08:00AM
Jun 4, 2026 08:00AM
May 19, 2026 08:01AM
May 19, 2026 08:00AM
May 19, 2026 04:00AM Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer
May 18, 2026 08:00AM
May 7, 2026 04:05PM
Apr 2, 2026 08:02AM
Apr 2, 2026 08:00AM
Mar 10, 2026 08:00AM
Feb 18, 2026 08:01AM
Feb 18, 2026 08:00AM Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Jan 20, 2026 08:01AM
Jan 20, 2026 08:00AM
Jan 19, 2026 12:20PM
Jan 12, 2026 08:01AM
Jan 12, 2026 08:00AM
Dec 16, 2025 08:00AM
Dec 16, 2025 08:00AM Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone
Nov 18, 2025 08:01AM
Nov 18, 2025 08:00AM
Nov 6, 2025 08:00AM
Nov 4, 2025 08:00AM
Sep 30, 2025 08:01AM
Sep 30, 2025 08:00AM
Sep 5, 2025 04:30PM Lipocine to Present at H.C. Wainwright 27th Annual Global Investment Conference
Aug 26, 2025 08:00AM
Aug 5, 2025 08:00AM
Jun 30, 2025 06:53AM
Jun 26, 2025 08:04AM
Jun 26, 2025 08:00AM
Jun 23, 2025 08:00AM
Jun 10, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Lipocine Inc (LPCN)
Jun 9, 2025 08:02AM
Jun 9, 2025 08:00AM
May 22, 2025 08:00AM
May 14, 2025 08:00AM
May 8, 2025 08:00AM
May 6, 2025 08:07AM
May 6, 2025 08:00AM Lipocine Announces License and Supply Agreement for TLANDO® in Brazil
Mar 26, 2025 08:00AM
Mar 13, 2025 08:00AM
Mar 12, 2025 08:00AM
Feb 6, 2025 08:03AM
Feb 6, 2025 08:00AM
Dec 17, 2024 08:01AM
Dec 17, 2024 08:00AM FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis
Nov 18, 2024 08:00AM

327,804 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All